LIRAGLUTIDE and DIARRHOEA

Overview

DIARRHOEA is the #4 most commonly reported adverse reaction for LIRAGLUTIDE, manufactured by Novo Nordisk. There are 3,264 FDA adverse event reports linking LIRAGLUTIDE to DIARRHOEA. This represents approximately 4.1% of all 79,181 adverse event reports for this drug.

Patients taking LIRAGLUTIDE who experience diarrhoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DIARRHOEA is moderately reported among LIRAGLUTIDE users, representing a notable but not dominant share of adverse events.

Other Side Effects of LIRAGLUTIDE

In addition to diarrhoea, the following adverse reactions have been reported for LIRAGLUTIDE:

• NAUSEA — 7,005 reports
• BLOOD GLUCOSE INCREASED — 3,875 reports
• VOMITING — 3,364 reports
• PANCREATITIS — 2,318 reports
• WEIGHT DECREASED — 2,076 reports
• DECREASED APPETITE — 2,066 reports
• HEADACHE — 1,988 reports
• OFF LABEL USE — 1,728 reports
• FATIGUE — 1,635 reports
• DRUG INEFFECTIVE — 1,539 reports

Other Drugs Associated with DIARRHOEA

The following drugs have also been linked to diarrhoea in FDA adverse event reports:

Does LIRAGLUTIDE cause DIARRHOEA?

DIARRHOEA has been reported as an adverse event in 3,264 FDA reports for LIRAGLUTIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DIARRHOEA with LIRAGLUTIDE?

DIARRHOEA accounts for approximately 4.1% of all adverse event reports for LIRAGLUTIDE, making it a notable side effect.

What should I do if I experience DIARRHOEA while taking LIRAGLUTIDE?

If you experience diarrhoea while taking LIRAGLUTIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages